Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer

被引：1
|
作者：
Bolla, M. [1 ]
Fourneret, P. [1 ]
Descotes, J. -L. [2 ]
机构：
[1] CHU, Clin Univ Cancerol Radiotherapie, F-63011 Grenoble, France
[2] CHU, Clin Univ Urol, F-63011 Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷 / 12期
关键词：
high-risk prostate cancer; combination of external irradiation and androgen suppression;
D O I：
10.1684/bdc.2008.0755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment of high-risk prostate cancer-localized or locally advanced-is based on the combination of external irradiation and hormonal treatment by LHRH analogue (aLHRH) according to the results of phases III randomized trials RTOG and/or EORTC trials. These trials show a significant improvement of overall or specific survival. Localized prostate cancer require 6-month complete androgen blockade, while locally advanced prostate cancer need a long-term hormonal treatment for a duration ranging from 2,5 to 3 years. Some trials, which have a long follow-up show that the risk of cardiovascular death is not significantly increased by hormonal treatment.
引用
收藏
页码：1213 / 1218
页数：6
相关论文
共 50 条
  • [1] Management of high-risk prostate cancer: surgery or radiotherapy with hormonal treatment
    Soulie, M.
    Richaud, P.
    ONCOLOGIE, 2012, 14 (02) : 79 - 86
  • [2] Improving outcomes in high-risk prostate cancer with radiotherapy
    Polkinghorn, William R.
    Zelefsky, Michael J.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (06) : 333 - 337
  • [3] The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy
    Chierigo, Francesco
    Flammia, Rocco Simone
    Sorce, Gabriele
    Hoeh, Benedikt
    Hohenhorst, Lukas
    Tian, Zhe
    Saad, Fred
    Graefen, Marcus
    Gallucci, Michele
    Briganti, Alberto
    Montorsi, Francesco
    Chun, Felix K. H.
    Shariat, Shahrokh F.
    Guano, Giovanni
    Mantica, Guglielmo
    Borghesi, Marco
    Suardi, Nazareno
    Terrone, Carlo
    Karakiewicz, Pierre I.
    PROSTATE, 2023, 83 (07) : 695 - 700
  • [4] Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
    Foerster, Robert
    Zwahlen, Daniel Rudolf
    Buchali, Andre
    Tang, Hongjian
    Schroeder, Christina
    Windisch, Paul
    Vu, Erwin
    Akbaba, Sati
    Bostel, Tilman
    Sprave, Tanja
    Zamboglou, Constantinos
    Zilli, Thomas
    Stelmes, Jean-Jacques
    Telkhade, Tejshri
    Murthy, Vedang
    CANCERS, 2021, 13 (04) : 1 - 17
  • [5] Contemporary treatment of high-risk localized prostate cancer
    Tareen, Basir
    Kimmel, Joseph
    Huang, William C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1069 - 1076
  • [6] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Ingels, Alexandre
    de la Taille, Alexandre
    Ploussard, Guillaume
    CURRENT UROLOGY REPORTS, 2012, 13 (02) : 179 - 186
  • [7] A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer
    Burgess, Laura
    Roy, Soumyajit
    Morgan, Scott
    Malone, Shawn
    CANCERS, 2021, 13 (17)
  • [8] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Alexandre Ingels
    Alexandre de la Taille
    Guillaume Ploussard
    Current Urology Reports, 2012, 13 : 179 - 186
  • [9] Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy Implications for Treatment Optimization
    Foster, Benjamin
    Jackson, William
    Foster, Corey
    Dess, Robert
    Abu-Isa, Eyad
    McLaughlin, Patrick William
    Merrick, Gregory
    Hearn, Jason
    Spratt, Daniel
    Liauw, Stanley
    Hamstra, Daniel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 382 - 390
  • [10] Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer
    Mezeckis, Maris
    Vesprini, Danny
    Buryk, Vladyslav
    Miszczyk, Leszek
    Vjaters, Egils
    JOURNAL OF RADIOSURGERY AND SBRT, 2022, 8 (02): : 95 - 103
12345